EU in a nutshell! After months of UK jab scaremongering, German vaccine just 47% effective

Tony Blair hits out at ‘unjustified resistance’ to AstraZeneca

When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how we use your data, and your rights. You can unsubscribe at any time.

Numerous members of the EU27, including Germany – led by Chancellor Angela Merkel – and France, moved to restrict the use of the AstraZeneca vaccination among older people, citing concerns over isolated incidences of blood-clotting. However, initial data published by CureVac suggested its jab has an efficacy rate of just 47 percent, less than half that provided by two doses of AstraZeneca – although on the plus side, the vaccine has been proven to be safe.

The study, which involved 40,000 people in 10 countries in Europe and Latin America where there are a minim of 13 coronavirus strains in circulation, warned the jab “did not meet prespecified statistical success criteria” based on a second analysis of a large-scale trial.

The original COVID-19 strain was almost completely absent.

CureVac CEO Franz-Werner Haas admitted his disappointment at the results.

In a statement issued today, he said: “While we were hoping for a stronger interim outcome, we recognise that demonstrating high efficacy in this unprecedented broad diversity of variants is challenging.

“In addition, the variant-rich environment underlines the importance of developing next-generation vaccines as new virus variants continue to emerge.”

Of the people who took part in the trial, there were 134 COVID cases among people two weeks after they had received the second dose, with just one attributable to the original strain.

JUST IN: Quiet, Leo! Varadkar shamed for arrogant UK outburst

More than half (57 percent) were “variants of concern”, with another 21 percent from another first spotted in Pera, and another seven percent from a strain originating in Colombia.

The final results are due to be published at the end of the month.

Mr Haas added: “As we are continuing toward the final analysis with a minimum of 80 additional cases, the overall vaccine efficacy may change.”

The results will are a significant blow for the EU, which bought up most of the initial supply of the CureVac vaccine – likely to be more than 400 million doses.

DON’T MISS
Louise Minchin and Liz Truss spark BBC Breakfast fury over interview [INSIGHT]
GB News clash as host branded a ‘hypocrite’ in fiery vaccine debate [EXPLAINER]
Vaccines for children will NOT go ahead ministers told [ANALYSIS]

Twitter users likewise reacted negatively to the news, with one describing it as a “disaster” and another describing it as a “letdown” and asking: “Are there any reasons now #SputnikV to keep away from the German / EU market for no reason and without consideration …?”

Meanwhile, SPD health expert Karl Lauterbach posted: “It’s a shame, the team from Tubingen deserved success.”

Emmanuel Macron stirred up enormous controversy in January with his comments about AstraZeneca.

The French President told reporters: “The real problem on AstraZeneca is that it doesn’t work the way we were expecting it to.

“We’re waiting for the EMA [European Medicines Agency] results, but today everything points to thinking it is quasi-ineffective on people older than 65, some say those 60 years or older.”

Conversely, however, European Commission President Ursula von der Leyen floated the idea of a ban of the export of vital components of AstraZeneca’s jab to the UK unless the company first supplied the EU with the doses it had promised to provide.

The company’s shares sank 44.3 percent yesterday as markets reacted to the news, and were on course for their worst session since August 2020.

Speaking on the Unlocked media channel earlier this year, former Brexit Party MEP Martin Daubney lamented the EU’s attitude towards AstraZeneca, which he said had exposed it as a “self-serving, autocratic protection racket”.

He added: “Up until now, Brexiteers were the only ones paying attention, but now, everybody is, and can see them for the spivs and charlatans they are.

“Brexiteers knew this all along. Whereas Remainers feared leaving the EU would render the United Kingdom ‘small and isolated’, leavers instead saw ‘quick and nimble’.

“And my, how this vaccine debacle has proved us right.

“Proving that miracles can happen, even Der Bild, a German newspaper of record hailed the AstraZeneca crisis “the best advert for Brexit”.”

(Additional reporting by Monika Pallenberg)

Source: Read Full Article